The molecular integration of nutrient-and pathogen-sensing pathways has become of great interest in understanding the mechanisms of insulin resistance in obesity. The double-stranded RNA-dependent protein kinase (PKR) is one candidate molecule that may provide cross talk between inflammatory and metabolic signaling. The present study was performed to determine, first, the role of PKR in modulating insulin action and glucose metabolism in physiological situations, and second, the role of PKR in insulin resistance in obese mice. We used Pkr Ϫ/Ϫ and Pkr ϩ/ϩ mice to investigate the role of PKR in modulating insulin sensitivity, glucose metabolism, and insulin signaling in liver, muscle, and adipose tissue in response to a high-fat diet. Our data show that in lean Pkr Ϫ/Ϫ mice, there is an improvement in insulin sensitivity, and in glucose tolerance, and a reduction in fasting blood glucose, probably related to a decrease in protein phosphatase 2A activity and a parallel increase in insulin-induced thymoma viral oncogene-1 (Akt) phosphorylation. PKR is activated in tissues of obese mice and can induce insulin resistance by directly binding to and inducing insulin receptor substrate (IRS)-1 serine307 phosphorylation or indirectly through modulation of c-Jun N-terminal kinase and inhibitor of B kinase ␤. Pkr Ϫ/Ϫ mice were protected from high-fat diet-induced insulin resistance and glucose intolerance and showed improved insulin signaling associated with a reduction in c-Jun N-terminal kinase and inhibitor of B kinase ␤ phosphorylation in insulin-sensitive tissues. PKR may have a role in insulin sensitivity under normal physiological conditions, probably by modulating protein phosphatase 2A activity and serine-threonine kinase phosphorylation, and certainly, this kinase may represent a central mechanism for the integration of pathogen response and innate immunity with insulin action and metabolic pathways that are critical in obesity. (Endocrinology 153: 5261-5274, 2012)
tion and/or deficiency in TLR4 are protected from dietinduced obesity (DIO) and/or insulin resistance and are substantially protected from the ability of systemic lipid infusion to suppress insulin signaling in muscle and reduce insulin-mediated changes in systemic glucose metabolism (12, 13) .
Besides TLR, it is important to search for other molecules that could also integrate nutrient-and pathogensensing pathways. Only a few molecules have emerged with the potential for such a role. One such molecule is the double-stranded RNA (dsRNA)-dependent protein kinase (PKR), which is a critical component of the innate immune response against virus infection. Its cellular actions are mediated by modulating cell signaling and translational regulation. To be enzymatically active, latent PKR needs to be activated by binding to one of its critical activators, dsRNA or PKR-activating protein. Previous papers demonstrated that PKR is able to activate two serine kinases that are important mediators of insulin resistance: c-Jun N-terminal kinase (JNK) and inhibitor of B kinase ␤ (IKK␤) (14 -16) . JNK is also activated in situations of endoplasmic reticulum (ER) stress, which play an important role in the development of insulin resistance and diabetes. In this regard, PKR also has an important role in ER stress, and the blockage of PKR activity protects against ER stress (17, 18) .
Recently, Nakamura et al. (18) , by using the kinase domain-defective PKR-deficient mice, showed that PKR can respond to nutrient signals as well as ER stress and coordinate the activity of other critical inflammatory kinases, such as JNK, to regulate insulin action and metabolism, suggesting that PKR may, at least in part, integrate the mechanisms of insulin resistance.
However, it was previously demonstrated that there are two knockouts of PKR that might present some differences related to immunological responses (19) . The mouse used by Nakamura et al. (18) has target deletion of exon 12, which corresponds to the C terminus of the PKR (CPkr Ϫ/Ϫ ), expresses a truncated mouse PKR protein, and retains the dsRNA-binding properties of wild type (WT).
The other mouse has a deletion of exons 2 and 3, corresponding to the N-terminal domain of PKR (N-Pkr Ϫ/Ϫ ), and expresses a truncated protein that is defective in dsRNA binding but remains catalytically active. These mice show different cell signaling responses and indicate that investigation of the metabolic profile of the N-Pkr Ϫ/Ϫ mouse is important to confirm previous data (18) or unravel other roles of PKR in insulin sensitivity and signaling.
In addition, it is important to mention that PKR is part of the insulin signal transduction pathway, downstream of the thymoma viral oncogene-1 (Akt), and after insulin stimulation, PKR is dephosphorylated by protein phosphatase (PP)1 and has its activity reduced (20) . When activated, PKR is also able to bind and activate PP2A. However, the role of PKR in the control of insulin sensitivity in physiological situations has yet to be investigated.
The present study, using N-Pkr Ϫ/Ϫ mice, was performed to determine, first, the role of PKR in modulating insulin action and glucose metabolism in physiological situations, and second, the role of PKR in insulin resistance in obese mice. Our data show that in N-Pkr Ϫ/Ϫ mice, there is an improvement in insulin sensitivity as well as in glucose tolerance and a reduction in fasting blood glucose, probably related to a decrease in PP2A phosphatase activity and a parallel increase in insulin-induced Akt phosphorylation, as well as a decrease in glucagon secretion.
On the other hand, in DIO mice, the absence of PKR protects from obesity and insulin resistance by preventing the activation of JNK and IKK␤, indicating that PKR is an important modulator of insulin signaling under normal physiological conditions and in obesity.
Materials and Methods
Male Pkr Ϫ/Ϫ and littermate controls (Pkr ϩ/ϩ ) from the University of Campinas Central Animal Breeding Center were used in the experiments. All antibodies were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA) with the exception of p-PKR Thr451 , obtained from Upstate Biotechnology (Charllottesville, VA), and standard reagents were from Sigma (St. Louis, MO).
Animal care
All animal care protocols and procedures were approved by the ethics committee at the State University of Campinas. We maintained mice on a 12-h light, 12-h dark cycle in a temperature-controlled barrier facility with free access to water and food. Pkr Ϫ/Ϫ mice were obtained by disruption of Pkr gene introduced in embryonic stem cells, which were injected into C57BL/6 blastocysts. The chimeric mice were bred to C57BL/6 mice and the progeny homozygous for the disrupted allele identified by PCR and Southern blotting, as previously described (21) . Six-weekold male Pkr Ϫ/Ϫ and Pkr ϩ/ϩ mice were divided into two groups and assigned to receive two kinds of diet: a standard rodent chow and water ad libitum or a high-fat diet (HFD) consisting of 55% calories from fat, 29% from carbohydrate, and 16% from protein for 16 wk.
Food intake determination
Food intake was determined by measuring the difference between the weight of chow given and the weight of chow at the end of a 24-h period.
Metabolic parameters evaluation
Body weight of HFD-fed mice was measured weekly. Blood glucose levels were measured using glucometer (OptiumXceed, Abbott, Libertyville, IL). After an overnight fast (12 h), glucose tolerance test (GTT) was performed in all studied groups using 1.0 g/kg of glucose injection, as previously described (22) . Glucagon determinations during insulin-induced hypoglycemia (3 U/kg ip) were conducted in mice as previously described (23, 24) . Insulin, leptin, adiponectin (Millipore, St. Charles, MO), TNF-␣, and IL-6 (Thermo Fischer Scientific, Inc., Rockford, IL) were measured from serum and from macrophage culture medium (TNF-␣) using ELISA kits, following manufacturer's instructions.
Hyperinsulinemic-euglycemic clamp studies
After an overnight fast, mice were anesthetized and catheters inserted into the jugular vein (for insulin and glucose infusion) and femoral artery (for blood sampling). A 120-min hyperinsulinemiceuglycemic clamp was carried out with a prime continuous infusion of regular insulin at the rate of 30 mU/kg⅐min. Blood glucose was measured at 5-min intervals, and unlabeled glucose (5%) was infused at variables rates to maintain plasma glucose at fasting levels (25) . The basal rates of glucose turnover were measured by continuously infusing H]glucose (0.02 Ci/min) for 120 min, and blood samples (20 l) were taken at 100, 110, and 120 min after the start of the experiment for the determination of plasma [ 3 H]glucose concentration. The hepatic glucose output during the clamp procedure was therefore obtained from the difference between the whole-body glucose uptake and the rate of unlabeled glucose infusion as previously described (26) .
PP2A phosphatase assay
Liver and muscle of lean and HFD Pkr Ϫ/Ϫ and Pkr ϩ/ϩ mice were homogenized in phosphatase extraction buffer containing 20 mM imidazole-HCl, 2 mM EDTA, and 2 mM EGTA (pH 7.0), with 10 g/ml each of aprotinin, leupeptin, 1 mM benzamidine, and 1 mM phenylmethylsulfonyl fluoride. The samples were centrifuged at 11,000 rpm for 20 min and supernatants immunoprecipitated with anti-PP2A-C subunit, anti-PKR, and anti-Akt overnight at 4 C on constant agitation. Then, protein A agarose was added to immunoprecipitate for immunocomplexes formation for 2 h at 4 C on agitation and washed four times. Then, samples were incubated for 10 min at 30 C with the threonine phosphopeptide (K-R-Pt-I-R-R), supernatants transferred to a 96-well plate, malachite green solution was added, and color developed within 15 min at room temperature was detected with a plate reader, according to the manufacturer´s instructions (PP2A Immunoprecipitation Phosphatase Assay kit; Millipore).
Peritoneal macrophage isolation
Pkr Ϫ/Ϫ and Pkr ϩ/ϩ mice were killed by cervical dislocation, abdominal wall was exposed, and sterile PBS injected into cavity. After a 10-sec gentle shake, peritoneal lavage fluid containing cells was withdrawn and plated on cell culture dishes in RPMI 1640 supplemented with fetal bovine serum 10% at 37 C for 1 h. Then, adherent macrophages (Ͼ90% of the cells) were treated with palmitate as previously described (13) . Then, culture medium was collected for cytokine determination and cells' proteins extracted and analyzed by immunoblotting.
Glucose uptake and immunoblotting in isolated muscles
Soleus muscles from Pkr Ϫ/Ϫ and Pkr ϩ/ϩ mice were excised and preincubated for 30 min at 37 C, in Krebs-Ringer bicarbonate buffer pregassed for 30 min with 95% O 2 /5% CO 2 containing 5.6 mM glucose (pH 7.4), with agitation at 120 rpm. After this period, the muscles were transferred to other vials containing the same buffer supplemented with 0.3 Ci/ml D-[U-
14 C] glucose, incubated for 1 h, under similar conditions at resting tension, in the absence or presence of 10 mU/ml insulin, and incubated or not with palmitate (100 M) for 4 h. After treatment, glucose uptake was measured, and muscles were homogenized for protein analysis. For insulin signaling proteins evaluation, a 5-min insulin stimulation was performed before protein extraction, as described previously (27) .
Polyinosinic-polycytidylic acid (poly I:C) treatment
Lean Pkr ϩ/ϩ mice were treated with poly I:C (Merck KGaA, Darmstadt, Germany) or vehicle. Four hours after an ip injection (15 mg/kg), the mice were anesthetized, and liver and muscle were removed and homogenized in protein extraction buffer for immunoprecipitation assays.
Tissue extraction, immunoprecipitation, and immunoblotting
Overnight-fasted mice were anesthetized, and right after assurance of loss of pedal and corneal reflexes, the abdominal cavity was opened, the vena cava exposed, and 0.1 ml of saline with or without insulin (10 Ϫ6 M) was injected. This is equivalent to injection of 60 g of insulin or approximately 1.5 U per animal. After the injection, liver (90 sec), muscle, and adipose tissue (180 sec) were removed, minced coarsely, and homogenized in specific extraction buffer as previously described (28) . Tissue extracts were incubated with antiinsulin receptor substrate (IRS)-1, anti-PKR, and anti-PKR-like ER kinase (PERK) and immunoprecipitated by 6MB Protein A Sepharose (GE Healthcare, Uppsala, Sweden). The immunoprecipitates and whole-tissue protein extracts were resolved by SDS-PAGE and immunoblotted with specific antibodies as previously described (29) .
O 2 consumption determination
O 2 consumption was measured in fed animals through an indirect open circuit calorimeter (Oxymax Deluxe System; Columbus Instruments, Columbus, OH), as described previously (30) .
Statistical analysis
Results are expressed as mean Ϯ SEM. Statistical analysis were performed by two-way ANOVA with Bonferroni test for post hoc comparisons and Student's t test where necessary. Level of significance adopted was, at least, P Ͻ 0.05.
Results

Glucose homeostasis and insulin sensitivity in
We did not observe any differences in body weight and in food intake between Pkr Ϫ/Ϫ mice and their littermates ( Fig. 1 , A and B). We then investigated the physiological role of PKR in insulin sensitivity and glucose tolerance in mice lacking PKR (Pkr Ϫ/Ϫ mice). There was a decrease in fasting and fed blood glucose levels in Pkr Ϫ/Ϫ mice, in parallel with a decrease in serum insulin levels, suggesting an increment in insulin action (Fig. 1 , C and D). We also investigated insulin sensitivity in these animals by performing hyperinsulinemic-euglycemic clamp studies. The glucose infusion rate of Pkr Ϫ/Ϫ mice was higher, and after insulin infusion, we also observed a more marked suppression of hepatic glucose output, indicating an increased insulin sensitivity ( Fig. 1 , E-G). To further confirm the reduction in glucose output, we performed immunoblotting of phosphoenolpyruvate carboxykinase and glucose 6-phosphatase key enzymes in gluconeogenesis, and observed that Pkr Ϫ/Ϫ showed reduced expression of these proteins when compared with Pkr ϩ/ϩ mice (Fig. 1H ). The glucose tolerance of Pkr Ϫ/Ϫ mice during ip GTT showed lower levels of blood glucose at all time points during the test (Fig. 1I ). We then investigated both basal and insulininduced glucose uptake in the isolated muscle of control and Pkr Ϫ/Ϫ mice. The results showed an increase in basal and in insulin-induced glucose uptake in isolated muscle of Pkr Ϫ/Ϫ compared with Pkr ϩ/ϩ mice (Fig. 1J) . In fed mice, the blood glucose levels were higher in Pkr ϩ/ϩ , but the serum glucagon levels were similar to Pkr Ϫ/Ϫ . However, after an insulin challenge (3 U/kg), blood glucose decreased in both groups. Although blood glucose levels after 30 and 60 min of insulin injection were much lower in Pkr Ϫ/Ϫ mice, serum glucagon levels showed a blunted increase in these mice compared with the controls. Interestingly, by correlating blood glucose and serum glucagon, we observed lower levels of serum glucagon in Pkr Ϫ/Ϫ mice for similar blood glucose levels (Fig. 1K) . We also measured circulating cytokines. The results showed that levels of TNF-␣ and IL-6 were significantly reduced in Pkr Ϫ/Ϫ mice (Fig. 1L ).
Insulin signaling in Pkr
We next examined insulin signaling in the liver and muscle of Pkr Ϫ/Ϫ mice. The results showed that, in muscle, there was an increase in insulin-induced IR␤ tyrosine phosphorylation level in Pkr Ϫ/Ϫ mice (Fig. 2B) ; and in liver and muscle of Pkr Ϫ/Ϫ mice, there was a clear increase in insulin-induced phosphorylation of Akt with no significant changes in IRS-1 tyrosine phosphorylation (Fig. 2, A-F) . We found no changes in JNK, IKK␤, and IRS-1 serine307 phosphorylation levels in the liver and muscle in either strain (Fig.  3, A and B) . Conversely, in the adipose tissue, there was a reduction in JNK phosphorylation in Pkr Ϫ/Ϫ mice (Fig. 3C ).
PP2A activity associated with Akt is reduced in liver and muscle of Pkr ؊/؊ mice
Recently, it was suggested that PKR is intricately involved in regulating the insulin signaling process through a feedback mechanism. The phosphorylation of PKR is down-regulated by insulin through the IRS-phosphatidylinositol 3 kinase-AKT-PP1 pathway; PKR may also inhibit insulin signaling by activation of PP2A, which will dephosphorylate Akt, reducing its activity. This implies that PKR binds and activates PP2A, which, in turn, binds and dephosphorylates Akt. We then investigated PP2A phosphatase activity in PP2A, PKR, and in Akt immunoprecipitates in liver and muscle of Pkr Ϫ/Ϫ mice, because these tissues showed improved insulin signaling. The results showed that in PP2A immunoprecipitates, PP2A phosphatase activity was clearly reduced in muscle, and only a mild reduction was observed in liver (Fig. 3, D (Fig. 4A) . Figure 4B shows that palmitate potently induced TNF-␣ release in the medium of WT macrophages but not in the medium of PKR-deficient macrophages. Together, these data suggest that FFA are capable of using PKR to induce an inflammatory response in macrophages.
We next examined glucose uptake in isolated muscle from Pkr Ϫ/Ϫ and WT mice in the presence of 100 M palmitate for 4 h. Palmitate treatment reduced insulinstimulated glucose uptake by approximately 40% in isolated soleus muscle from control mice, and in isolated soleus muscle from Pkr Ϫ/Ϫ mice, this decrease was only about 20% (Fig. 4C ). In accordance with this finding, palmitate induced a down-regulation in insulin-induced Akt phosphorylation in isolated soleus muscle of control mice but not in the muscle of Pkr Ϫ/Ϫ mice (Fig. 4D) . Palmitate treatment induced degradation of IB␣ and increased JNK phosphorylation in isolated muscle from control mice but not in isolated muscle from Pkr Ϫ/Ϫ mice (Fig. 4E) .
Effect of HFD on metabolic parameters and insulin sensitivity in Pkr ؊/؊ mice Mice lacking PKR and controls were placed on a HFD for 16 wk. WT mice on the HFD developed obesity, whereas weight gain in Pkr Ϫ/Ϫ mice was significantly lower (Fig. 5A ). Epididymal fat pads were reduced in Pkr Ϫ/Ϫ mice (Fig. 5B ). Food intake was not different between Pkr Ϫ/Ϫ and WT mice on HFD (Fig. 5C ). In Pkr Ϫ/Ϫ mice on HFD, blood glucose and serum insulin levels were significantly lower than those in controls on HFD (Fig. 5,  D and E). Hyperinsulinemic-euglycemic clamp studies confirmed increased insulin sensitivity in these mice, because we observed an increase in glucose infusion rate, and after insulin stimulation, we also observed a remarkable suppression of hepatic glucose production (Fig. 5, F-H) . In accordance, glucose tolerance was increased in Pkr Ϫ/Ϫ mice at 16 wk after the start of HFD compared with controls on the same diet (Fig. 5I) . In addition, our data related to leptin and adiponectin levels are in accordance with previous data in PKR knockout mice described by Nakamura et al. (18) . The reduction in leptin levels in HFDfed Pkr Ϫ/Ϫ mice compared with control mice is consistent with reduced adiposity (Fig. 5J) . On the other side, the levels of adiponectin were similar in Pkr (Fig. 5P) , indicating that energy expenditure may be a potential mechanism for body weight reduction. This improvement in insulin sensitivity was accompanied by an increase in insulin signaling. In the liver and muscle of Pkr Ϫ/Ϫ mice on HFD, there was a clear increase in insulin-induced phosphorylation of IR␤, IRS-1, and Akt, compared with littermates after 16 wk on HFD (Fig. 6, A-F) . This down-regulation of insulin-induced insulin signaling in HFD-fed 
FIG. 1.
Pkr Ϫ/Ϫ mice physiological parameters. Twenty-two-week-old Pkr ϩ/ϩ and Pkr Ϫ/Ϫ mice body weight (A) and food intake (B). Blood glucose levels (C) and serum insulin concentration (D) in Pkr ϩ/ϩ and Pkr Ϫ/Ϫ mice in the fasted and fed condition. Glucose infusion rate during hyperinsulinemic-euglycemic clamp study in Pkr ϩ/ϩ and Pkr Ϫ/Ϫ mice (E). Serum insulin levels were similar between groups during the hyperinsulinemic-euglycemic clamp (F). Hepatic glucose production during the clamp (G). Representative immunoblots for phosphoenolpyruvate carboxykinase (PEPCK) and glucose 6-phosphatase (G6Pase) in liver lysates from Pkr ϩ/ϩ and Pkr Ϫ/Ϫ mice (H). Blood glucose levels during GTT (I). Isolated muscle glucose uptake after a 5-min insulin stimulation (J). Serum glucagon and blood glucose levels in Pkr ϩ/ϩ and Pkr Ϫ/Ϫ mice during insulin-induced hypoglycemia (K). TNF-␣ and IL-6 serum levels in Pkr ϩ/ϩ and Pkr Ϫ/Ϫ mice (L mice was accompanied by an increase in PKR, JNK, IKK␤, and IRS-1 serine307 phosphorylation levels in the liver and muscle of WT mice after 16 wk of HFD (Fig. 7, A and B) but not in Pkr Ϫ/Ϫ mice. Similar results were observed in the adipose tissue (Fig. 7C) . Taken together, these data suggest that in animals on HFD, protection from an increase in IRS-1 serine307 phosphorylation levels, and in JNK and IKK␤ activity, seems to be an important mechanism that may protect Pkr Ϫ/Ϫ mice from insulin resistance. (Fig. 7, D and E) . These data suggest that PP2A activity bound to Akt does not have a role in the protection of Pkr Ϫ/Ϫ mice from insulin resistance.
IRS-1 is a substrate of PKR
We next investigated, in control and HFD-fed mice, whether PKR can directly bind to IRS-1 and block insulin 
FIG. 5.
Loss of PKR prevents DIO and insulin resistance. Pkr ϩ/ϩ (n ϭ 10) and Pkr Ϫ/Ϫ (n ϭ 10) mice were weighed weekly for 16 wk on HFD (A). Pkr Ϫ/Ϫ mice have decreased epididymal fat pad weight on HFD (B), and no difference in food intake (C), compared with Pkr ϩ/ϩ . Fasting blood glucose and serum insulin levels after 16 wk on HFD (n ϭ 10 each group) (D and E). Glucose infusion rate during hyperinsulinemic-euglycemic clamp study of Pkr ϩ/ϩ and Pkr Ϫ/Ϫ mice on HFD (n ϭ 6 each group) (F). Serum insulin levels were similar between groups during hyperinsulinemiceuglycemic clamp (G). Hepatic glucose production during the clamp (H). Blood glucose levels during GTT (n ϭ 10 each group) (I). Serum leptin and adiponectin concentrations at 16 wk on HFD (n ϭ 10 each group) (J and K). TNF-␣ and IL-6 serum levels of Pkr action. In lean mice stimulated with poly I:C, our data showed in parallel to an increased PKR phosphorylation also an increased interaction between this kinase and IRS-1 (Fig. 7F ). In addition, in HFD-fed mice, PKR was detectable by Western blot analysis after immunoprecipitation with an anti-IRS-1 antibody, demonstrating a potential interaction between these proteins. To verify the interaction between PKR and IRS-1, we next performed a reciprocal experiment, where we immunoprecipitated PKR from protein extracts of HFD-fed mice and detected IRS-1 by immunoblotting analysis. This experiment also detected the interaction between these two proteins. To assess the specificity of the PKR-IRS-1 interaction, we also examined the relation between IRS-1 and PERK, which is the closest homolog of PKR in mammals, and did not detect any interaction between these proteins in HFD-fed mice (Fig. 7G ).
Discussion
Our data show that PKR, which was originally identified as a pathogen sensor and a proposed regulator of the innate immune response against viral infections in higher eukaryotes, may have a role in the physiological regulation of glucose homeostasis. It is activated in tissues of DIO mice and knockout of PKR protects mice from DIO-induced insulin resistance. An interesting finding is that in PKR knockout mice, fasting plasma glucose is reduced, and there is an improvement in insulin action, a more marked suppression of glucose output, and in insulin-induced Akt phosphorylation. This improvement in insulin signaling appears to be directly at the levels of Akt, without changes in IRS-1 tyrosine phosphorylation, suggesting that these changes are not related to IRS-1 serine307 phosphorylation or JNK and/or IKK␤ activity. PKR is known to phosphorylate the regulatory subunit of PP2A, which then activates the catalytic subunit of PP2A inducing its phosphatase activity (31) . Therefore, the PKR-PP2A pathway should have a role in physiological modulation of insulin signaling, because PP2A can dephosphorylate and inactivate Akt. Our data show that PP2A activity in whole-protein extracts and in Akt immunoprecipitates are reduced in Pkr Ϫ/Ϫ mice. This may contribute to the increase in insulin-induced Akt phosphorylation and in insulin action in these mice, suggesting that PKR may have a role in the modulation of physiological insulin action. On the other side, we did not find an increase in PP2A activity in DIO animals nor a reduction in this enzyme activity in Pkr Ϫ/Ϫ mice on HFD. It is important to mention that the insulin signaling proteins upstream of Akt were activated in Pkr Ϫ/Ϫ mice on HFD, which certainly results in increased Akt activity, because these proteins can modulate insulin-induced Akt phosphorylation. These data suggest that the PKR-PP2A-Akt pathway may have a role in physiological modulation of Akt phosphorylation and insulin action but not in DIO mice.
It is interesting to mention that during the insulin tolerance test, the increase in circulating glucagon levels was attenuated in PKR-deficient mice, suggesting that the lower levels of glucagon observed in different levels of blood glucose may have a role in the reduced fasting blood glucose and the improvement in glucose tolerance observed in Pkr Ϫ/Ϫ mice. However, the role of glucagon in hepatic glucose output in this animal model deserves further exploration.
Recently (18), it was demonstrated that the kinase domain-defective PKR-deficient mice did not present an improvement in insulin sensitivity under normal physiological conditions, such as our knockout mice presented. Although this may be related to differences in genetic background, it is important to consider that some differences between our results and the results of Nakamura et al. (18) may be related to differences in PKR knockout mouse used, as previously described. In our experiments, we used the N-Pkr Ϫ/Ϫ mouse, which expresses a truncated protein that is defective in dsRNA binding but remains catalytically active. The mouse used by Nakamura et al. (18) , C-Pkr Ϫ/Ϫ , expresses a truncated mouse PKR protein and retains the dsRNA-binding properties of the WT. These mice show very different cell signaling responses. The N-Pkr Ϫ/Ϫ displays an impaired nuclear factor B (NF-B) activation in response to dsRNA and resistance to apoptosis in response to TNF-␣ or lipopolysaccharide. These alterations related to activation of NF-B were not observed in C-Pkr Ϫ/Ϫ , which respond normally to dsRNA or TNF-␣, indicating that the catalytic activity of PKR is dispensable for NF-B activation/gene transcription, as demonstrated by normal IB␣ phosphorylation in response to dsRNA. It is possible that the dsRNA-binding domain of PKR, which is located in its N terminus, is important for the signaling capacity of PKR. Thus, the absence of this domain may account for the signaling defects described in N-Pkr Ϫ/Ϫ mice. We suggest that PKR may be able to modulate cell signaling independent of its kinase ability. In this regard, we speculate that through its N-terminal domain, PKR may mediate protein-protein interactions, subcellular localization, and compartmentalization of molecules. In this regard, our study in Pkr Ϫ/Ϫ mice allowed us to demonstrate that PKR may have a role in insulin sensitivity and glucose metabolism under normal physiological conditions, probably by controlling Akt activity.
One important point in the relationship between insulin resistance and inflammatory pathways is related to integration of the signals from different molecules with similar biological functions. In this regard, Nakamura et al. (18) and our study suggest that PKR may have an important role coordinating the relationships between inflammatory pathways and insulin action. Previously, a direct interaction of PKR with IKK␤/NF-B pathway had been demonstrated (14) , which we confirm by showing that in Pkr Ϫ/Ϫ mice on HFD, there is no activation of this pathway. Another important serine kinase in insulin resistance is JNK, which has also reduced activity in liver and muscle of Pkr Ϫ/Ϫ mice on HFD. In addition, both studies show that under conditions of insulin resistance, as induced by TNF-␣ or HFD, PKR associates with and induces IRS-1 serine phosphorylation. These data indicate that PKR fits as a candidate molecule that coordinates intracellular signals of innate immunity with insulin action, integrating nutrient and pathogen sensing in relation to metabolic homeostasis. In rodents, protection from diet-induced insulin resistance and obesity is usually associated with an increase in energy expenditure, a reduction in food intake, or both. Our data show an increase in O 2 consumption along with UCP-1 expression in brown adipose tissue of Pkr Ϫ/Ϫ mice on HFD, without change in food intake, suggesting that these animals have an increased energy expenditure, which contributed to their protection from DIO. The function of PKR has been most extensively investigated in cells of the immune system, including macrophages. The relevance of macrophages to the pathogenesis of insulin resistance in obesity and type 2 diabetes has been emphasized in the past (8, 9, (32) (33) (34) (35) , so potential activation of macrophage PKR by FFA can now be readily linked to insulin resistance. In addition, to the extent that PKR is expressed in tissues metabolically active for insulin action, such as liver, muscle, and adipose tissue, an ability of FFA to activate PKR in these tissues could be important as well, and our data show that both possibilities are relevant. We have demonstrated that palmitate acts on isolated mouse peritoneal macrophages to induce IB degradation and activate JNK. Probably these activations are PKR dependent, because in PKR-deficient macrophages, palmitate does not have these effects. In isolated muscle, palmitate is able to induce insulin resistance and induce PKR, JNK, IKK␤, and IRS-1 serine307 phosphorylation. In isolated muscle from Pkr Ϫ/Ϫ mice, palmitate is not able to induce insulin resistance, and no activation of JNK and IKK␤ is observed. Skeletal muscle insulin resistance is a well-known metabolic complication of obesity affecting glucose and fatty acid metabolism. In the past few years, several groups have demonstrated an increase in JNK activity in mice skeletal muscle in obese mice (29, 36) . Sabio et al. (37) demonstrated that Jnk1 Ϫ/Ϫ mice display lowered fasting blood glucose and insulin concentrations and protection against obesity-induced insulin resistance, relative to control mice, suggesting enhanced glucose disposal into skeletal muscle. However, another study has shown that insulininduced, but not contractile-stimulated, JNK1 activation is impaired in ob/ob mice (38) . It is important to mention that in liver and adipose tissue, the activation of JNK in obese mice is related, at least in part, to an increase in ER stress (39) . However, it is well established that obesity does not induce ER stress in muscle (40) . In this regard, the activation of JNK may be related to different pathways, but certainly, PKR may have an important role in JNK activity in muscle, because Pkr Ϫ/Ϫ mice on HFD do not show any increase in JNK activity. It is well known that PKR mediates responses to both extrinsic and intrinsic stress signals. In addition to dsRNA and other forms of RNA, this kinase is also activated by TLR1, TLR3, TLR4, TNF receptor, fatty acids, and ceramides (41) (42) (43) (44) . Being activated by different stimuli suggests that PKR may have an important role in other situations of insulin resistance, besides obesity and hepatitis C, and may have a determinant role in the metabolic abnormalities that emerge during the course of many infections. In this regard, the activation of PKR seems to be a common mechanism of insulin resistance, because PKR can sense nutrients, infections, and probably other metabolic products not yet related to insulin resistance, such as endogenous RNA species produced during metabolic or ER stress.
In summary, our data show that PKR may have a role in insulin sensitivity under normal physiological conditions, probably by modulating PP2A and Akt phosphorylation. Certainly, this kinase may represent a central mechanism for the integration of pathogen response and innate immunity with insulin action and metabolic pathways that are critical in obesity in mice. The potential for PKR as a site for new therapeutic approaches of insulin resistance deserves further exploration.
